Karo Pharma AB – Company Profile and SWOT Analysis

Karo Pharma AB – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Karo Healthcare AB (Karo Healthcare), formerly Karo Pharma AB, is a healthcare company which focuses on development and commercialization of pharmaceutical products. The company provides prescription medicines and over the counter products to pharmacies and directly to the healthcare sector across various countries with the Nordic region and Europe as its core markets. Karo Pharma has developed BabySlide, a product that is developed to reduce stretch marks during childbirth. The company has brands spanning six key categories which include intimate care, dermatology, foot care, wellness, Rx pharma care, pain, cough & cold. Karo Pharma AB is headquartered in, Stockholm, Sweden.

Scope

• Detailed information on Karo Pharma AB required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Karo Pharma AB in the form of a SWOT analysis

• An in-depth view of the business model of Karo Pharma AB including a breakdown and examination of key business segments

• News about Karo Pharma AB, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Karo Pharma AB and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Karo Pharma AB as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Karo Pharma ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Meda AB

Genmab AS

Dyax Corp

BioInvent International AB

Amgen Research Copenhagen

Active Biotech AB

Genmab AS

Amgen Research Copenhagen

Active Biotech AB

BioInvent International AB

Meda AB

Dyax Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Karo Pharma AB - Key Facts

Karo Pharma AB - Key Employees

Karo Pharma AB - Key Employee Biographies

Karo Pharma AB - Major Products and Services

Karo Pharma AB - History

Karo Pharma AB - Company Statement

Karo Pharma AB - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Karo Pharma AB - Business Description

Business Segment: Digital First

Overview

Performance

Business Segment: OTC

Overview

Performance

Business Segment: Rx

Overview

Performance

Geographical Segment: Denmark

Performance

Geographical Segment: Finland

Performance

Geographical Segment: France

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Norway

Performance

Geographical Segment: Rest of Europe

Performance

Geographical Segment: Rest of World

Performance

Geographical Segment: Sweden

Performance

Geographical Segment: USA

Performance

Karo Pharma AB - Corporate Strategy

Karo Pharma AB - SWOT Analysis

SWOT Analysis - Overview

Karo Pharma AB - Strengths

Karo Pharma AB - Weaknesses

Karo Pharma AB - Opportunities

Karo Pharma AB - Threats

Karo Pharma AB - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Karo Pharma AB, Recent Deals Summary

Section 4 – Company’s Recent Developments

Jul 03, 2023: Babak Peyami Joins Karo’s Corporate Management Team as new Head of Digital Commerce

Jan 16, 2023: Michael Kaltenborn appointed CSDO at Karo

Jul 21, 2022: Karo Pharma : Interim report H1 2022

Apr 12, 2022: Karo Pharma publishes the 2021 annual report

Feb 25, 2022: Karo Pharma : Year-end report 2021

Section 5 – Appendix

Methodology

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Karo Pharma AB, Key Facts

Karo Pharma AB, Key Employees

Karo Pharma AB, Key Employee Biographies

Karo Pharma AB, Major Products and Services

Karo Pharma AB, History

Karo Pharma AB, Subsidiaries

Karo Pharma AB, Key Competitors

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Karo Pharma AB, Recent Deals Summary

List of Figures

List of Figures

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports